179 related articles for article (PubMed ID: 1654482)
1. The leukemic B-cell population of patients with monoclonal lymphocytosis of undetermined significance (MLUS) are functionally distinct from the chronic lymphocytic leukemia (CLL) derived cell population.
Aman P; Mellstedt H
Leuk Res; 1991; 15(8):715-9. PubMed ID: 1654482
[TBL] [Abstract][Full Text] [Related]
2. Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS).
Garcia C; Rosén A; Kimby E; Aguilar-Santelises M; Jondal M; Bjorkholm M; Holm G; Mellstedt H
Leuk Res; 1989; 13(1):31-7. PubMed ID: 2536870
[TBL] [Abstract][Full Text] [Related]
3. Higher proliferative response in B-chronic lymphocytic leukemia (B-CLL) as compared to B-monoclonal lymphocytosis of undetermined significance (B-MLUS) after stimulation with Staphylococcus aureus and anti-CD40 monoclonal antibodies.
Garcia CA; Rosén A; Aguilar-Santelises M; Jondal M; Mellstedt H
Leuk Res; 1993 Nov; 17(11):933-9. PubMed ID: 8231234
[TBL] [Abstract][Full Text] [Related]
4. Clonal cell surface structures related to differentiation, activation and homing in B-cell chronic lymphocytic leukemia and monoclonal lymphocytosis of undetermined significance.
Kimby E; Mellstedt H; Björkholm M; Holm G
Eur J Haematol; 1989 Nov; 43(5):452-9. PubMed ID: 2612619
[TBL] [Abstract][Full Text] [Related]
5. CD5-negative phenotype of monoclonal B-lymphocytosis of undetermined significance (MLUS).
Wang C; Amato D; Fernandes B
Am J Hematol; 2002 Feb; 69(2):147-9. PubMed ID: 11835355
[TBL] [Abstract][Full Text] [Related]
6. Differences in blood T and NK cell populations between chronic lymphocytic leukemia of B cell type (B-CLL) and monoclonal B-lymphocytosis of undetermined significance (B-MLUS).
Kimby E; Mellstedt H; Nilsson B; Björkholm M; Holm G
Leukemia; 1989 Jul; 3(7):501-4. PubMed ID: 2471902
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of monoclonal B lymphocytosis of undetermined significance (MLUS) and chronic lymphocytic leukemia (CLL) with weak CD5 expression from CD5(-) CLL.
Wang C; Amato D; Rabah R; Zheng J; Fernandes B
Leuk Res; 2002 Dec; 26(12):1125-9. PubMed ID: 12443886
[TBL] [Abstract][Full Text] [Related]
8. Infection of leukaemic B lymphocytes by Epstein Barr virus.
Doyle MG; Catovsky D; Crawford DH
Leukemia; 1993 Nov; 7(11):1858-64. PubMed ID: 8231253
[TBL] [Abstract][Full Text] [Related]
9. Expression of adhesion molecules CD11/CD18 (Leu-CAMs, beta 2-integrins), CD54 (ICAM-1) and CD58 (LFA-3) in B-chronic lymphocytic leukemia.
Kimby E; Rincón J; Patarroyo M; Mellstedt H
Leuk Lymphoma; 1994 Apr; 13(3-4):297-306. PubMed ID: 7519509
[TBL] [Abstract][Full Text] [Related]
10. Lymphoma-like monoclonal B cell lymphocytosis in a patient population: biology, natural evolution, and differences from CLL-like clones.
Vander Meeren S; Heyrman B; Renmans W; Bakkus M; Maes B; De Raeve H; Schots R; Jochmans K
Ann Hematol; 2018 Jul; 97(7):1219-1227. PubMed ID: 29492600
[TBL] [Abstract][Full Text] [Related]
11. The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemia.
Rasul E; Salamon D; Nagy N; Leveau B; Banati F; Szenthe K; Koroknai A; Minarovits J; Klein G; Klein E
PLoS One; 2014; 9(8):e106008. PubMed ID: 25162594
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of helper factors (IL-1 alpha, IL-1 beta and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and beta 2-microglobulin in patients with B-CLL and benign B lymphocytosis.
Aguilar-Santelises M; Loftenius A; Ljungh C; Svenson SB; Andersson B; Mellstedt H; Jondal M
Leuk Res; 1992; 16(6-7):607-13. PubMed ID: 1386130
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines.
Wendel-Hansen V; Sällström J; De Campos-Lima PO; Kjellström G; Sandlund A; Siegbahn A; Carlsson M; Nilsson K; Rosén A
Leukemia; 1994 Mar; 8(3):476-84. PubMed ID: 8127151
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal B cell lymphocytosis.
Lanasa MC; Allgood SD; Weinberg JB
Leuk Lymphoma; 2010 Aug; 51(8):1386-8. PubMed ID: 20629528
[TBL] [Abstract][Full Text] [Related]
15. Activation and immortalization of leukaemic B cells by Epstein-Barr virus.
Walls EV; Doyle MG; Patel KK; Allday MJ; Catovsky D; Crawford DH
Int J Cancer; 1989 Nov; 44(5):846-53. PubMed ID: 2555307
[TBL] [Abstract][Full Text] [Related]
16. EBV infection of B-CLL cells in vitro potentiates their allostimulatory capacity if accompanied by acquisition of the activated phenotype.
Avila-Cariño J; Lewin N; Yamamoto K; Tomita Y; Mellstedt H; Brodin B; Rosén A; Klein E
Int J Cancer; 1994 Sep; 58(5):678-85. PubMed ID: 8077053
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal B cell lymphocytosis: clinical and population perspectives.
Caporaso NE; Marti GE; Landgren O; Azzato E; Weinberg JB; Goldin L; Shanafelt T
Cytometry B Clin Cytom; 2010; 78 Suppl 1(Suppl 1):S115-9. PubMed ID: 20839332
[TBL] [Abstract][Full Text] [Related]
18. CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it?
Scarfò L; Dagklis A; Scielzo C; Fazi C; Ghia P
Semin Cancer Biol; 2010 Dec; 20(6):384-90. PubMed ID: 20816789
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal B-cell lymphocytosis.
Maitre E; Troussard X
Best Pract Res Clin Haematol; 2019 Sep; 32(3):229-238. PubMed ID: 31585623
[TBL] [Abstract][Full Text] [Related]
20. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
